Halina Bartosik-Psujek
Department of Neurology
Medical University of Lublin
Jaczewskiego 8
Lublin
Poland
Name/email consistency: high
- Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone. Bartosik-Psujek, H., Psujek, M., Jaworski, J., Stelmasiak, Z. Acta Neurol. Scand. (2011)
- Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis. Bartosik-Psujek, H., Tabarkiewicz, J., Pocinska, K., Stelmasiak, Z., Rolinski, J. Mult. Scler. (2010)
- Immunomodulatory effects of IFN-beta and lovastatin on immunophenotype of monocyte-derived dendritic cells in multiple sclerosis. Bartosik-Psujek, H., Tabarkiewicz, J., Pocinska, K., Radej, S., Stelmasiak, Z., Rolinski, J. Arch. Immunol. Ther. Exp. (Warsz.) (2010)
- The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis. Bartosik-Psujek, H., Stelmasiak, Z. J. Neural. Transm (2006)
- The interleukin-10 levels as a potential indicator of positive response to interferon beta treatment of multiple sclerosis patients. Bartosik-Psujek, H., Stelmasiak, Z. Clin. Neurol. Neurosurg (2006)
- Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients. Bartosik-Psujek, H., Stelmasiak, Z. J. Neural. Transm (2005)
- Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse. Bartosik-Psujek, H., Stelmasiak, Z. Eur. Neurol. (2004)